vTv Therapeutics Inc. (VTVT)
NASDAQ·Healthcare·Biotechnology
$32.44
+2.69%
Mkt Cap $95.58M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$51.33
Range $47.00 – $58.00
Implied Upside
+58.2%
Consensus $51.33 vs current $32.44
NASDAQ·Healthcare·Biotechnology
$32.44
+2.69%
Mkt Cap $95.58M
No recent rating data.
Price Target (3 analysts)
$51.33
Range $47.00 – $58.00
+58.2%
Consensus $51.33 vs current $32.44